Estimation of Problematic Drug Use in Spain - Examples of estimation based in surveys- Data and thought

Size: px
Start display at page:

Download "Estimation of Problematic Drug Use in Spain - Examples of estimation based in surveys- Data and thought"

Transcription

1 Prevalence and patterns of drug use among general population. GPS Indicator. Annual Expert Meeting June EMCDDA (Lisbon) Estimation of Problematic Drug Use in Spain - Examples of estimation based in surveys- Data and thought Spanish Observatory on Drugs Julia Gonzalez Rosario Sendino Noelia Llorens Begoña Brime Aurora Ruiz Elena Alvarez (speaker)

2 Problematic Drug Use INTRODUCTION Concept and aspects to take into account Source of information and methods, in Spain EXAMPLES Cocaine PDU estimation based in surveys (frequency & age/vulnerability) Objective. Methods. Results. Cannabis PDU base in surveys (scales). Objective. Methods. Results. DISCUSSION Utility of surveys to estimate PDU, combination of different methods

3 Population Drug users Problematic users Approach of of problematic users... The drug use is is causing, the users (or (or others), negative physical, psychological or or social consequences or or hightrisk of of having them. EMCDDA Until 2012: problem drug use is injecting drug use or regular and/or long-term use of opiates, cocaine and/or amphetamines 2013: focuses on high-risk drug use. Drug use that is causing actual harm (negative consequences) to the person (including dependence but also other health, psychological or social problem) or is placing the person at a high probability/risk of suffering such harms

4 Population Drug users Problematic users It is useful to identified problematic user to orienteand implement policies (prevention, treatment, social needs, harm reduction, economics and human resources). Focus in target population. How many? It is possibleto estimate the number and some characteristics of problematic users. Profile? It is necessary define criteria, based in evidences, consensus and practical issues, in order to improve the comparability. Multidisciplinary work.

5 Type of drug alcohol, cocaine, cannabis, heroine prevalence Users characteristic Health situation, previous pathologies, pregnancy, age Some aspects to take into account Consequences for users or others Physic, psychological, social.. Pattern of use Frequency, chronicity, route of administration intensity, (how much -gr./hour), poliproblematics Accidents, infections, mental diseases SOURCES OF INFORMATION:available information or new indicators. Surveys (general population, specific group ) treatment centers, traffic offenses, judicial system, mortality, emergencies facilities, social services, infectious diseases registries, etc. METHODS: Direct or indirect estimations surveys, scales, combinated methods Standardization of definitions, methodologies and analysis comparability

6 1) SURVEYS General pop. Survey (15-64 y.o) Student survey (14-18 y.o) Others: Prison, specific population... Information sources in Spain Strengths of periodic surveys: Periodic and long series: biennale from Big sample: 20,000 a 30,000 Complete questionnaire (50 min): basic + special modules. International comparability. 2) DRUG INDICATORS Hospital emergencies Drug Mortality Treatment Demand indicator infectious diseases Problem drug use annual since (2011) Annual since (2010) Annual since (2011) Annual since 1986 Annual since ) EXTERNAL SOURCES. Supply indicators, etc.

7 Main Methods for PDU estimates in Spain ,6 73,6 40,2 32,4 Last year prevalence. Spain 2010/ ,6 26,4 EDADES (15-64 a.) 2011 General population survey 2011(15-64 y.o) Student survey (14-18 y.o) ESTUDES (14-18 a) ,2 2,6 0,7 1,7 0,6 1,6 0,4 2,1 0,10,6 Alcohol Tabaco Cannabis Cocaína Éxtasis Anfetaminas Alucinógenos Heroína Alcohol AUDIT scale. General Population Survey Cannabis PDU scales (CAST. SDS. DSM-IV. M-CIDI) Students surveys Cocaine Direct estimation (frequency and age). General Population surveys y Heroine Indirect estimation. Multiplier method GPS & TDI From 2006 to Source: Spanish Observatory on Drugs

8 INTRODUCTION. OBJETIVE. METHOD.. RESULTS. DISCUSSION. OBJETIVE Estimation of cocaine problematic drug users in Spain, using general population survey, based in frequency and age (vulnerability) METHOD Source of information General population survey y.o. National coverage. Face to face questionnaire. 22, 128 questionnaires. Criteria No clear consensus, no evidence based criteria 1) Frequency based How many times in a period of time (month/year) do a person consume?. Person (15-64 y.o.) who used cocaine 30 days or more within the last 12 months OR who used cocaine 10 days or more within the last 30 days 2) Frequency & age (vulnerability) 20 years old?? Phisic/psycic/socialvulnerability. Implement prevention in early ages. Persons (15-20 y.o) who used cocaine 10 d or more within the last 12 month AND who used cocaine from 1 to 3 d within in the last 30 days PLUS persons (21 to 64 y.o.) who used cocaine 30 days or more within the last 12 months OR who used cocaine 10 d or more within the last 30 days.(more than 20 y.o)

9 COCAINE PROBLEMATIC DRUG USE, SPAIN 2011 Using GPS: frequency (frequency + age) Population (15-64 y.o.).) Cocaine users Problematic users Life time: 8.8% n= Last year: 2.2% n= Last month: 1.1% n= ( ) Can be considerer cocaine PDU IN Spain in 2011: 0.39% (0.41%) of population y.o. 4.5% (4.7%) of (15-64 y.o.) life time prevalence users 17.0% (17.9%) of (15-64 y.o.) last year prevalence users 35.6% (37.5%) of (15-64 y.o. last month prevalence users Source: Spanish Observatory on Drugs

10 PREVALENCE VS PROBLEMATIC DRUG USE % Problematic drug use (%). Spain 2009 & Based in frequency & age in GPS (15-64 y.o) , ,7 17,9 15,0 31,2 37,4 Continuity Among people ever using cocaine: 1 out of 4 consumed last year 1 out of 7 consumed last month. 0 CP alg. vez CP Ult. año CP Ult. mes PU life time PU last year PU last month Cocaine prevalence (%) in general population (15-64 y.o). Spain Cocaine prevalence (%) in student (14-18 y.o) Spain Life alguna timevez Last último year año Last último mont mes 8 Prevalence results by them 6 self doesn't 4 show a complete picture Source: Spanish Observatory on Drugs

11 Cross indicator analysis. COCAINE DRD cocaine with or without any other susbstances (nº) Nº Nº defunciones death Hospital emergency detected cocaine (nº) Nº Nº urgencias hospital emergencies hosp se detecta when cocaína cocaine is detected Seizures (kg/10) Incautaciones (Kg/10) Nº cocaine first treatment Nº primeros First treatments tratamiento for cocaine por cocaína (nº) % Last consumo last month último prevalence mes (%) y.o. años (%) y.o. Last Last month prevaelnce prevalence (%) y.o. (%) y.o. % consumo último mes años.. 4 3,5 3 2, , , Source: Spanish Observatory on Drugs

12 INTRODUCTION. OBJETIVE. METHOD.. RESULTS. DISCUSSION. OBJETIVES Psychometric evaluation of scales. European project on course. Estimation of cannabis problematic drug use (14-18 y.o). Spain, METHOD Year Scale CAST SDS DSM-IV CAST CAST SDS M-CIDI CAST N survey 26,454 30,183 31,967 26,000 N CAST (valid questionnaires last year) Source of information 3,569 7,173 6,303 In process Student survey y.o National coverage. self-administered questionnaires (45 min.) CAST-Cannabis Abuse Screening Test. 6 items. Measure social & healthconsequences for user and others. SDS-Severity of Dependence Scale. 5 items. Measure dependence. DSM-IV-American Psychiatric Association. 5 items for abuse and 13 for dependence. DSM-IV criteria. M-CIDI-Munich Composite International Diagnostic Interview.

13 CANNABIS PROBLEMATIC DRUD USERS (CAST) SPAIN, Population ( y.o.).) Cannabis last year users Problematic drug user (26.4% of total population) Problematic users. 15.3% among last year users. 4.6% among total population. Source: Spanish Observatory on Drugs

14 CANNABIS PDU TRENDS (CAST), SPAIN 2006, 2008, 2010 CAST results. Percentage of non problematic/low/high risk among cannabis last year users (14-18 y.o). 100% 80% 60% 40% 20% 13,3 14,3 15,3 20,7 18,6 19,9 66,0 67,1 64,8 Increase trends in cannabis problematic drug use in teenagers. 0% no No problemático problematic bajo Low riesgo risk alto High riesgo risk Year % of cannabis high risk users among population y.o Nº of cannabis high risk users among population y.o 73, , ,340

15 Cannabis prevalence(14-18 y.o). Spain Number of cannabis treatment demands. Spain, First treatment Life time Alguna vez en la vida Últimos Last year 12 meses Últimos Last mont 30 días Previous treatments % hospital emergenciesrelated to drug when cannabis is present. Spain Treatment episodes in< 18 years (%) different drugs. Spain, Source: Spanish Observatory on Drugs

16 Some thought based in our experience different scenarios dif. answers dif. methods. Conceptual definition depend of situation, drug, user characteristic, pattern of use. Look for a complete pictureusing multiples sources and different indicators. Available information. Triangulation of the information. Problematic use!! Look for right sources & methods. Are survey a good methods for estimate problematic use? Surveys can't answer everything but yes many things Part of the puzzle to understand drug use? First step to oriented specific studies?. Methods : -General population/specific population. -Scales (AUDIT, CAST, DSM-V ). -Frequency of use, age, others. -Surveys + other indicator. Some limitation: classics surveys limitations. Drug with low prevalence. Survey with small sample. High risk-social stigma. Out of sampling frame Surveys are a possible tool: -Available(more cost effective than create new indicator). -Robust(quality and trends). -Flexible(periodic modules, adapt to needs).

17 PDU concept Population Drug users PDU It is useful It is possible Continue working in define criteria, methods and source of information SURVEYS POSSIBLE TOOL Spanish Observatory on Drugs.

PDU (Problem drug use) revision summary

PDU (Problem drug use) revision summary European Monitoring Centre for Drugs and Drug Addiction PDU (Problem drug use) revision summary 20 February 2013 Danica Thanki and Julián Vicente Introduction This document is a summary of the concepts

More information

Trends in cannabis use and cannabis-related treatment demand in Switzerland

Trends in cannabis use and cannabis-related treatment demand in Switzerland Trends in cannabis use and cannabis-related treatment demand in Switzerland Etienne Maffli, Addiction Switzerland, Lausanne TDI and HRDU annual expert meetings, Lisbon, sept. 23-26 2014 Data sources available

More information

STATISTICAL BULLETIN 2016

STATISTICAL BULLETIN 2016 STATISTICAL BULLETIN Title: STATISTICAL BULLETIN Author: General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) / Monitoring and Information Directorate (DMI) / Statistics

More information

STATISTICAL BULLETIN 2015

STATISTICAL BULLETIN 2015 STATISTICAL BULLETIN Title: Author: General-Directorate for Intervention on Addictive Behaviours and Dependencies (SICAD) / Monitoring and Information Directorate (DMI) / Statistics and Research Division

More information

Estimating Cannabis Use disorder

Estimating Cannabis Use disorder Estimating Cannabis Use disorder Institut für Therapieforschung München by using measures of heavy use over time Elena Gomes de Matos 1) & Ludwig Kraus 1,2) 1) IFT Institut für Therapieforschung, Munich,

More information

Statistics on Drug Misuse: England, 2007

Statistics on Drug Misuse: England, 2007 Statistics on Drug Misuse: England, 2007 Summary For the first time, this annual statistical bulletin presents information on drug misuse among both adults and children. The topics covered include: Prevalence

More information

Perspectives for information on alcohol use in the EU

Perspectives for information on alcohol use in the EU EMCDDA Perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 20-21 March 2018 CNAPA meeting Topics in this presentation ESPAD project (now with EMCDDA) in students Alcohol ( Tobacco

More information

New patterns of drug use in Hungary

New patterns of drug use in Hungary New patterns of drug use in Hungary Gergely Horváth Hungarian National Focal Point PDU Annual Expert Meeting 2012 Lisbon, 25-26 September 2012 First glance From 2009 on decrease in heroin availability,

More information

Trends in injecting drug use in Europe

Trends in injecting drug use in Europe Trends in injecting drug use in Europe Linda Montanari, Bruno Guarita and Danica Thanki Annual Expert Meeting on Drug-Related Infectious Diseases Lisbon, 15-17 October Overview of the presentation 1) Information

More information

NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS. 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, November 2017

NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS. 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, November 2017 NEW TRENDS IN USE, CONSEQUENCES / DAMAGES AND MARKETS 2nd Annual Meeting of National Drug Observatories COPOLAD II Lisbon, 13-17 November 217 THE QUESTIONS In the last two years What recent changes and

More information

The italian interactive system for addiction data management

The italian interactive system for addiction data management The italian interactive system for addiction data management High risk drug use and drug treatment in Europe 2014 Bruno Genetti Lisbon 24-26 September 2014 Rationale Italian legislation governing drugs

More information

The drugs situation in Ireland: an overview of trends from 2005 to 2015.

The drugs situation in Ireland: an overview of trends from 2005 to 2015. The drugs situation in Ireland: an overview of trends from 2005 to 2015. July 2017 Geoff Bates Centre for Public Health at Liverpool John Moores University Contents Contents... 1 List of acronyms... 3

More information

Taking Stock of the 2009 PoA Research and Trend Analysis Branch

Taking Stock of the 2009 PoA Research and Trend Analysis Branch Taking Stock of the 2009 PoA Research and Trend Analysis Branch Eliminate or reduce significantly and measurably: The five targets Illicit cultivation of opium, coca, cannabis Illicit demand of drugs and

More information

Republic of Turkey- Ministry of Interior-Turkish National Police- Counter Narcotics Department Date of submission: Contact person:

Republic of Turkey- Ministry of Interior-Turkish National Police- Counter Narcotics Department Date of submission: Contact person: In the UNGASS outcome document, Member States reiterated their commitment to supporting efforts at all levels, based on the common and shared responsibility, to effectively address and counter the world

More information

PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe

PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe UPDATED 16. 5. 2014 PERSPECTIVES ON DRUGS Emergency health consequences of cocaine use in Europe Every year, several thousands of cocainerelated emergencies are reported in Europe, along with hundreds

More information

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D

INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14

More information

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis Improving our capacity of identification and reporting on emerging trends New methods and new areas of analysis Monitoring challenges Rapidly changing, globalised drug market Growth of online and virtual

More information

Annual report 2009: the state of the drugs problem in Europe

Annual report 2009: the state of the drugs problem in Europe Annual report 2009: the state of the drugs problem in Europe Alessandro Pirona, Rome 05/11/2009 European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) Established: 1993 Seat: Lisbon Staff: 100

More information

TDI 3.0 implementation. TDI Prevalence. Linda Montanari, Bruno Guarita

TDI 3.0 implementation. TDI Prevalence. Linda Montanari, Bruno Guarita TDI 3.0 implementation TDI Prevalence Linda Montanari, Bruno Guarita Lisbon, 21 22 September 2015 Workshop 3.0 The role and value of data from drug treatment services (TDI working group) TDI implementation

More information

Project Meeting Prague

Project Meeting Prague Project Meeting Prague IO1 Assessment 9.11.217 CHRISTINA PADBERG ON BEHALF OF FRANKFURT UAS Current Status Assessment matrix was fully evaluated Experts have been interviewed, Interviews were fully evaluated

More information

Psychometric properties of the RAPS4 in Argentina, Mexico and United States.

Psychometric properties of the RAPS4 in Argentina, Mexico and United States. Psychometric properties of the RAPS4 in Argentina, Mexico and United States. Mariana Cremonte UMDP CONICET Mar del Plata, Argentina Rubén Ledesma UNMDP CONICET Mar del Plata, Argentina Cheryl Cherpitel

More information

João Goulão, MD. EVIDENCE-BASED POLICIES 21 April April João Goulão

João Goulão, MD. EVIDENCE-BASED POLICIES 21 April April João Goulão INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security DRUGS SUMMIT EUROPEAN, LATIN AMERICAN AND CARIBBEAN MAYORS AND CITIES April 21 23, 2010 Lugo, Spain OEA/Ser.L/XIV.4.1

More information

Design of studies to evaluate and validate scales and indicators of problematic drug use. Report on advances in Activity 1.

Design of studies to evaluate and validate scales and indicators of problematic drug use. Report on advances in Activity 1. Design of studies to evaluate and validate scales and indicators of problematic drug use Report on advances in Activity 1.4 COPOLAD General objective To procuce necessary methodological designs for National

More information

Harms and harm reduction workbook. Country X

Harms and harm reduction workbook. Country X Harms and harm reduction workbook Country X 1 Table of Contents T0. Summary... 3 T1. National profile... 3 T1.1 Drug-related deaths... 3 T1.2 Drug related acute emergencies... 4 T1.3 Drug related infectious

More information

Injection of new psychoactive drugs in Romania multi-indicator analysis

Injection of new psychoactive drugs in Romania multi-indicator analysis Injection of new psychoactive drugs in Romania multi-indicator analysis Psycho-Sociologist Lavinus Sava - RNAA LISBON 26-27 October 2013 Romania, 2012 2012 stabilization of drug phenomenon in Romania,

More information

Statistics on Drug Misuse: England, 2008

Statistics on Drug Misuse: England, 2008 Statistics on Drug Misuse: England, 2008 Summary This annual statistical report presents information on drug misuse among both adults and children. It includes a focus on young adults. The topics covered

More information

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 HIV/AIDS Think Tank meeting: EMCDDA report Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015 European Drug Report 2015 Drop o Trends in seizures by substance from 2009 o Drug and related long-term

More information

Public drug policies Catalonia

Public drug policies Catalonia Public drug policies Catalonia Public Health Agency of Catalonia Xavier Majó Roca Catalonia Barcelona Territory: 32.000 km2 Population: 7.523.000 M Own language and culture 1. What s happened in Catalonia

More information

Solving the ecstasy puzzle case study in the Netherlands

Solving the ecstasy puzzle case study in the Netherlands Solving the ecstasy puzzle case study in the Netherlands Margriet van Laar Head of Drug Monitoring department & Netherlands Focal Point Meeting on 20 years EMCDDA Key Indicators Ecstasy Many studies show

More information

Overview of drug-induced deaths in Europe - What does the data tell us?

Overview of drug-induced deaths in Europe - What does the data tell us? Overview of drug-induced deaths in Europe - What does the data tell us? João Matias, Isabelle Giraudon, Julián Vicente EMCDDA expert group on the key-indicator Drug-related deaths and mortality among drug

More information

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

EMCDDA-update HIV/HCV among people who inject drugs: situation and response EMCDDA-update HIV/HCV among people who inject drugs: situation and response Dagmar Hedrich EU Think Tank HIV/AIDS: 24-25 November 2015, Luxembourg Latest European overview Multi-indicator based analysis

More information

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic

Rapporteur report of Session 2: New Trends in TDI clients. Thursday, September 20th 2012, ( Room 106) Chair: Dragica Katalinic Rapporteur report of Session 2: New Trends in TDI clients Thursday, September 20th 2012, (14.30 16.00 Room 106) Chair: Dragica Katalinic Rapporteur: Christine Marchand-Agius 1. Presentation on new trends

More information

A review of drug-related deaths in seven Northern European countries

A review of drug-related deaths in seven Northern European countries A review of drug-related deaths in seven Northern European countries Tim Millar a & Andy McAuley b a) Division of Psychology & Mental Health, School of Health Sciences, The University of Manchester b)

More information

Substance misuse among young people The data for

Substance misuse among young people The data for Substance misuse among young people The data for 28-9 EFFECTIVE TREATMENT CHANGING LIVES www.nta.nhs.uk Substance misuse among young people The data for 28-9 More teenagers are receiving help for drug

More information

research on addic ORMING PDU REVISION: ELIMINARY RESULTS OF LITERATURE

research on addic ORMING PDU REVISION: ELIMINARY RESULTS OF LITERATURE research on addic ORMING PDU REVISION: ELIMINARY RESULTS OF LITERATURE VIEW oject content ect CT.12.EPI.0.046.1.0 to assist the EMCDDA in e aspects of the process of Problem drug use key icator revision

More information

The issues facing Europe

The issues facing Europe The issues facing Europe An overview Andrew Cunningham Supply reduction and New Drugs unit 28 May 2015 European Drug Report 2015 https://youtu.be/vzzyp3k6psk 2 Opiates (heroin) Europe s main drug issue

More information

World Drug Report 2018 Methodology Report. Research and Trend Analysis Branch UNODC, Vienna

World Drug Report 2018 Methodology Report. Research and Trend Analysis Branch UNODC, Vienna World Drug Report 2018 Methodology Report Research and Trend Analysis Branch UNODC, Vienna Table of Contents 1. Introduction... 1 Sources of information... 1 2. Data on drug use and health consequences

More information

12/13/2016. Gender-sensitive prevention and treatment services for alcohol and drug users in Belgium. 6 What about What we know

12/13/2016. Gender-sensitive prevention and treatment services for alcohol and drug users in Belgium. 6 What about What we know Gender-sensitive prevention and treatment services for alcohol and drug users in Belgium Julie Schamp Wouter Vanderplasschen 2 What about What we know Who we are What we aim to do What we plan to do Preliminary

More information

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges

Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Viewpoints on future dissemination of take-home naloxone: opportunities and challenges Dagmar Hedrich & Isabelle Giraudon, EMCDDA Bergen, 1 September 2015 OVERDOSEKONFERANSEN 2015 ThINCBergen2015: The

More information

Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland

Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland Scottish Blues- Benzodiazepines and Drug Related Deaths in Scotland EMCDDA Sep. 25 th 2014 Dr Saket Priyadarshi Associate Medical Director NHS Greater Glasgow and Clyde Vice-Chair, National Forum on Drug

More information

Presented at: Annual expert meeting on Drug-related deaths (DRD) and Drug-Related infectious diseases (DRDI), October 2014, EMCDDA, Lisbon

Presented at: Annual expert meeting on Drug-related deaths (DRD) and Drug-Related infectious diseases (DRDI), October 2014, EMCDDA, Lisbon Assessing the gender effect in mortality risk and excess mortality from natural and external causes among heroin and cocaine users in Spain Does being heroin or cocaine user add a differential risk of

More information

Combination of various data bases and estimation methods to better estimate the market from the demand and the supply side and consequences

Combination of various data bases and estimation methods to better estimate the market from the demand and the supply side and consequences EU project JUST/2010/DPIP/AG/1410: New methodological tools for policy and programme evaluation, www.drugpolicyevaluation.eu Combination of various data bases and estimation methods to better estimate

More information

The epidemiology of HIV infection in Greece HIV/AIDS reporting system

The epidemiology of HIV infection in Greece HIV/AIDS reporting system HIV outbreak in IDUsin Greece Update on situation and responses Anastasios Fotiou, REITOX Focal Point-Greece Foteini Giannou, Office of HIV and STIs, Hellenic Centre for Disease Control and Prevention

More information

4. Problem drug use Introduction

4. Problem drug use Introduction 4. Problem drug use 4.1. Introduction Problem use: general context A set of studies and work has been conducted in recent years to establish a new estimate of the number of problematic drug users in France.

More information

DRUG USE LEVELS IN FRANCE IN 2010

DRUG USE LEVELS IN FRANCE IN 2010 DRUG USE LEVELS IN FRANCE IN 2010 First results from the Health Barometer survey (OFDT /INPES analysis) OFDT 3 avenue du Stade de France 93218 Saint-Denis La Plaine cedex Tel : 01 41 62 77 16 Fax : 01

More information

1 Cannabis problems in context: understanding increasing in treatment demand

1 Cannabis problems in context: understanding increasing in treatment demand 1 Cannabis problems in context: understanding increasing in treatment demand 1.1 Demand for treatment for cannabis use 1.1.1 Proportion of clients with primary cannabis problems Cannabis can be found as

More information

Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany

Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany Prof. Dr Heino Stöver Faculty of Health and Social Work University of Applied Sciences Frankfurt, Germany The Treatment Demand Indicator (TDI) 12th Annual Expert Meeting 2012 Lisbon (EMCDDA), Portugal

More information

Professor Paul I Dargan

Professor Paul I Dargan General Overview of the Euro-DEN Dataset: 5529 presentations with acute drug toxicity in 16 sentinel European centres Professor Paul I Dargan Guy s s and St Thomas NHS Foundation Trust and King s s College

More information

Drug consumption among roma population

Drug consumption among roma population NATIONAL ANTIDRUG AGENCY Drug consumption among roma population High risk drug use and drug treatment in Europe 2014 Special populations and drug problems Lisbon, 24 September 2014 General characteristics

More information

Drug Misuse Research Division

Drug Misuse Research Division Drug Misuse Research Division contents Occasional Paper No. 1/ 2002 - Background - NDTRS methodology - Treatment as an indicator of drug misuse - Treatment provision - Extent of the problem - Socio-demographic

More information

Statistics on Drug Misuse: England, 2012

Statistics on Drug Misuse: England, 2012 Statistics on Drug Misuse: England, 2012 Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved. Copyright 2012, The Health and Social Care Information Centre. All Rights Reserved.

More information

Cannabis trends in France TDI data

Cannabis trends in France TDI data Cannabis trends in France TDI data Tanja Bastianić High risk drug use and drug treatment in Europe 2014 Lisbon, September 2014 Cannabis in general population in France 2 2 Cannabis in France Cannabis is

More information

Estimating cannabis consumption in seven EU countries by differentiating different user groups

Estimating cannabis consumption in seven EU countries by differentiating different user groups Improving Mental Health by Sharing Knowledge Estimating cannabis consumption in seven EU countries by differentiating different user groups Margriet van Laar 1, Tom Frijns 1, Franz Trautmann 1, Linda Lombi

More information

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia

Part of the Continuum of Care. Harm Reduction. Gino Vumbaca President Harm Reduction Australia Part of the Continuum of Care Harm Reduction Gino Vumbaca President Harm Reduction Australia What is Harm Reduction The defining features are the focus on the reduction of harm, rather than on the prevention

More information

Research Methodology. Introduction 10/18/2016. Introduction. User name: cp6691 Password: stats.

Research Methodology. Introduction 10/18/2016. Introduction.   User name: cp6691 Password: stats. Research Methodology 1 http://spectrum.troy.edu/drsmall/ Web Page User name: cp6691 Password: stats 2 Pieces of the Puzzle Chapter 2 Literature Review Chapter 1 Chapter 3 Methodology No Data Collection

More information

Legal and institutional framework of combating drugs abuse in the. Republic of Croatia

Legal and institutional framework of combating drugs abuse in the. Republic of Croatia Government of the Republic of Croatia Legal and institutional framework of combating drugs abuse in the Republic of Croatia 9th EXASS Net meeting Zagreb, 11-12 October 2012 Content of the presentation

More information

The Netherlands Drug Situation Summary

The Netherlands Drug Situation Summary The Netherlands Drug Situation 2010 - Summary Developments in drug law and policies (chapter 1) The intended new Dutch drug policy was delayed because the Dutch government fell in February 2010. The resigned

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic

More information

2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point. SPAIN New Development, Trends. Reitox

2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point. SPAIN New Development, Trends. Reitox 2014 NATIONAL REPORT (2013 data) TO THE EMCDDA by the Reitox National Focal Point SPAIN New Development, Trends Reitox INDEX SUMMARY 5 1. DRUG POLICY: LEGISLATION, STRATEGIES AND ECONOMIC ANALYSIS 13

More information

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA

NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA NEEDLE AND SYRINGE PROGRAMMES MONITORING IN LITHUANIA Dr. Audronė Astrauskienė Drug control department under the Government of the Republic of Lithuania 2010 10 25 Harm reduction services development in

More information

Consumption of new substances with psychoactive effects (NSPE)

Consumption of new substances with psychoactive effects (NSPE) Consumption of new substances with psychoactive effects (NSPE) Aurora LEFTER, sociologist Bogdan GHEORGHE, MD LISBON 20-21 SEPTEMBER 2012 Survey Risks Assessment of the use of new psychoactive substances

More information

Economic and Social Council

Economic and Social Council United Nations E/CN.3/2014/19 Economic and Social Council Distr.: General 9 December 2013 Original: English Statistical Commission Forty-fifth session 4-7 March 2014 Item 4 (d) of the provisional agenda*

More information

Marijuana in Washington, DC. Arrests, Usage, and Related Data

Marijuana in Washington, DC. Arrests, Usage, and Related Data Marijuana in Washington, DC Arrests, Usage, and Related Data Jon Gettman, Ph.D. The Bulletin of Cannabis Reform www.drugscience.org November 5, 2009 1 Introduction This state report is part of a comprehensive

More information

Most recent data, analyses and feed-back from the 2016 DRID national updates

Most recent data, analyses and feed-back from the 2016 DRID national updates Most recent data, analyses and feed-back from the 216 DRID national updates Eleni Kalamara, Dagmar Hedrich, Linda Montanari, Isabelle Giraudon 15-16 June 217, Lisbon DRID/TDI annual expert meeting DRID

More information

Workshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation

Workshop summary. Exchange on data collection challenges related to new psychoactive substances use. Presentation of the situation Workshop summary Presentation of the situation Among countries participating in the workshop the level and characteristics of NPSs use showed great diversity. The use and the problem use of NPSs is a major

More information

The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends. ATS trends, programme progress and planned expansion

The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends. ATS trends, programme progress and planned expansion The Global S.M.A.R.T. Programme: Synthetics Monitoring: Analysis, Reporting and Trends ATS trends, programme progress and planned expansion Regional SMART Workshop, Bangkok, 5-6 August 2010 Beate Hammond,

More information

1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses

1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses Simultaneous launches: Vienna and Bangkok 13 Sep 2011 1. Background 2. The Big Picture 3. Global trends 4. Regional trends E/SE Asia 5. Effective responses The international drug control system 1. Based

More information

QUESTIONNAIRE. Submission Information. Information for follow-up purposes. Head of International Drug Policy, Home Office

QUESTIONNAIRE. Submission Information. Information for follow-up purposes. Head of International Drug Policy, Home Office IMPLEMENTATION OF THE RECOMMENDATIONS ADOPTED BY THE TWENTY-SIXTH SESSION OF HONLEA, LATIN AMERICA AND THE CARIBBEAN, SANTIAGO, CHILE 3-7 OCTOBER 2016 QUESTIONNAIRE Submission Information Name of country:

More information

Recent trends in drug problems and service provision in Greece

Recent trends in drug problems and service provision in Greece Recent trends in drug problems and service provision in Greece Anastasios Fotiou Epidemiology Unit The Greek Reitox focal point of the EMCDDA at the Understanding the dynamics, nature and scale of drug

More information

NATIONAL DRUG INFORMATION NETWORK

NATIONAL DRUG INFORMATION NETWORK REGIONAL WORKSHOP ON DRUG INFORMATION NETWORKS (DINs) BERMUDA S NATIONAL DRUG INFORMATION NETWORK Antigua & Barbuda August 1, 2012 Dr. Kyla Raynor, Senior Research Officer/Policy Analyst Where did the

More information

DMRI Drug Misuse Research Initiative

DMRI Drug Misuse Research Initiative DMRI Drug Misuse Research Initiative Executive Summary Comorbidity in the national psychiatric morbidity surveys Research Report submitted to the Department of Health in February 2004 Report prepared by:

More information

Acute Drug Toxicity Data

Acute Drug Toxicity Data Acute Drug Toxicity Data Recreational drug use is common Systematic data is available on: Prevalence of drug use Drug seizures Use of treatment agencies for problem drug use Drug-related fatalities There

More information

JSNA Substance Misuse

JSNA Substance Misuse JSNA Substance Misuse Introduction 9.1. Substance misuse causes less damage to health in absolute population terms than tobacco or alcohol. However, its association with crime and antisocial behaviour

More information

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the

More information

Evidence table for systematic reviews

Evidence table for systematic reviews Evidence table for systematic reviews Topic: CB use and dependence Reviewer: CMF Abbreviations: y- years Reference Research Parameters Population Outcomes Funding Additional comments Bibliographic reference

More information

Methodology World Drug Report 2017

Methodology World Drug Report 2017 Methodology World Drug Report 2017 Considerable efforts have been made over the years to improve the estimates presented in the World Drug Report, which rely, to a large extent, on information submitted

More information

POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere)

POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE. Last data available Indicator (sphere) POLICY, LEGISLATION, ECONOMIC ANALYSIS AND MEDIA COVERAGE Amendments in laws and legal regulations number 8 2 NDC Expenditures for activities against drugs and drug addictions in Bulgaria [1] BGN 1 102

More information

Psychosis with coexisting substance misuse

Psychosis with coexisting substance misuse Psychosis with coexisting substance misuse Clinical case scenarios for primary, secondary and third sector services Implementing NICE guidance March 2011 OTC α blocker information sheet for GP s (2010)

More information

SPAIN New Development, Trends and In-depth Information on Selected Issues

SPAIN New Development, Trends and In-depth Information on Selected Issues 2013 NATIONAL REPORT (2012 data) FOR THE EMCDDA by the Reitox National Focal Point SPAIN New Development, Trends and In-depth Information on Selected Issues REITOX INDEX Summary (major developments, highlights,

More information

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes.

BROMLEY JOINT STRATEGIC NEEDS ASSESSMENT Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. 13. Substance Misuse Introduction Substance misuse is the harmful use of substances (such as drugs and alcohol) for non-medical purposes. The term substance misuse often refers to illegal drugs, but, some

More information

DRUG COURTS Study Day in Brussels 23 October 2015

DRUG COURTS Study Day in Brussels 23 October 2015 DRUG COURTS Study Day in Brussels 23 October 2015 The Portuguese Experience João Goulão General-Director for Intervention on Addictive Behaviors and Dependencies National Coordinator on Drugs, Drug Addiction

More information

Methodology World Drug Report 2010

Methodology World Drug Report 2010 Methodology World Drug Report 2010 Considerable efforts have been made over the years to improve the estimates presented in this report. Nonetheless, challenges remain in making such estimates because

More information

Methodology. Sources and limitations of data on the supply side

Methodology. Sources and limitations of data on the supply side Considerable efforts have been made over the last few years to improve the estimates presented in this report. Nonetheless, the data must still be interpreted with caution because of the clandestine nature

More information

LITERATURE REVIEW: BULGARIA

LITERATURE REVIEW: BULGARIA Directorate-General Justice, Freedom and Security LITERATURE REVIEW: BULGARIA THROUGHCARE WORKING IN PARTNERSHIP 1 CONTENTS 1.Drug use 3 1.1 Trends and statistics 3 1.2 Drug use amongst specific groups

More information

EMCDDA looks behind rising numbers of young people in cannabis treatment

EMCDDA looks behind rising numbers of young people in cannabis treatment 2004 ANNUAL REPORT: SELECTED ISSUES EMCDDA looks behind rising numbers of young people in cannabis treatment (25.11.2004 LISBON EMBARGO 10H00 CET/Brussels time) Specialised drug treatment centres in many

More information

Drug using mothers: retaining care of their children

Drug using mothers: retaining care of their children Drug using mothers: factors associated with retaining care of their children Gail Gilchrist 1 and Avril Taylor 2 1 L'Institut Municipal d'investigació Mèdica, Barcelona, Spain p g,, p 2 University of the

More information

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications

HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014

More information

Drug information systems: Principles, structures and indicators **

Drug information systems: Principles, structures and indicators ** FOR PARTICIPANTS ONLY E/CN.7/2000/CRP.3 3 March 2000 ORIGINAL: ENGLISH COMMISSION ON NARCOTIC DRUGS Forty-third session Vienna, 6-15 March 2000 Item 4(a) and (b) of the provisional agenda* Reduction of

More information

References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS

References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS References to Argentina Part 1 RECENT STATISTICS AND TREND ANALYSIS OF ILLICIT DRUG MARKETS A. EXTENT OF ILLICIT DRUG USE AND HEALTH CONSEQUENCES The global picture Cocaine In 2010, the regions with a

More information

ANNUAL REPORT ON THE DRUG SITUATION. Portugal Commissioned by the European Monitoring Centre on Drugs and Drug Addiction

ANNUAL REPORT ON THE DRUG SITUATION. Portugal Commissioned by the European Monitoring Centre on Drugs and Drug Addiction ANNUAL REPORT ON THE DRUG SITUATION Portugal - 2003 Commissioned by the European Monitoring Centre on Drugs and Drug Addiction Lisbon, October 2003 Table of Contents TABLE OF CONTENTS SUMMARY... 4 PART

More information

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch

Epidemiology of non medical use of prescription drugs. Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Epidemiology of non medical use of prescription drugs Kamran Niaz, Survey and Statistics Section, Policy Analysis and Research Branch Monitoring of the drug use situation: Annual reports questionnaire

More information

REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES

REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES REPORT OF THE 4 TH BIENNIAL MEETING OF CARIBBEAN NATIONAL OBSERVATORIES ON DRUGS SEPTEMBER 13 TO 16, 2011 Kapok Hotel Port of Spain, Trinidad and Tobago The fourth biennial meeting of Caribbean National

More information

Present and potential perspectives for information on alcohol use in the EU

Present and potential perspectives for information on alcohol use in the EU EMCDDA Present and potential perspectives for information on alcohol use in the EU Julian Vicente Luxembourg 7-8 June 2016 CNAPA meeting Topics in this presentation 1.- EMCDDA overview and its work on

More information

Horizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe

Horizontal Working Party on Drugs EMCDDA contribution towards a methodological framework for monitoring drugs and prison in Europe COUNCIL OF THE EUROPEAN UNION Brussels, 15 February 2013 5420/1/13 REV 1 CORDROGUE 7 SAN 19 NOTE from: to: Subject: EMCDDA Horizontal Working Party on Drugs EMCDDA contribution towards a methodological

More information

Global drug trends and sustainable development

Global drug trends and sustainable development Lau Global drug trends and sustainable development Chloé Carpentier Chief, Drug Research Section UNODC Göteborg, 15 November 2017 Global trends in estimated number of drug users and people with drug user

More information

The Scottish Burden of Disease Study, Drug use disorders technical overview

The Scottish Burden of Disease Study, Drug use disorders technical overview The Scottish Burden of Disease Study, 2016 Drug use disorders technical overview This resource may also be made available on request in the following formats: 0131 314 5300 nhs.healthscotland-alternativeformats@nhs.net

More information

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID

2 nd Meeting on detecting and responding to outbreaks of HIV among PWID 2 nd Meeting on detecting and responding to outbreaks of HIV among PWID Update on country situation: AUSTRIA Lisbon, 12 th October 201 Epidemiological update 2 HIV notifications in PWID Number of HIV cases

More information

Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC)

Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC) Drug Trafficking and Abuse - Impediments to development - Akira Fujino United Nations Office on Drugs and Crime (UNODC) Shanghai, 1909 Early days 1920s-30s Century of Drug Control BACKGROUND 19th century:

More information

Drug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS)

Drug and alcohol treatment in the North West of England 2008/09. Results from the National Drug Treatment Monitoring System (NDTMS) Drug and alcohol treatment in the North West of England 2008/09 Results from the National Drug Treatment Monitoring System (NDTMS) Drug and alcohol treatment in the North West of England 2008/09 - Results

More information

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry

Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry Prepared by: Dr. Elizabeth Woodward, University of Toronto Resident in Psychiatry In broad terms, substance use disorders occur when a substance is used in a compulsive manner with a lack of control over

More information